Gut microbiota and gut-derived metabolites in defining multiple sclerosis phenotypic continuum

• by Federico Montini, Ashutosh Mangalam, Burcu Zeydan, Joseph Murray, Orhun H. Kantarci

• July 1, 2026

Non-Linear Measures of Movement Variability in Multiple Sclerosis: A Clinical Narrative Review of Lyapunov Exponent and Entropy Applications in Balance and Gait

• by Banakheiri, Tina , Panisset, Maya G., Galea, Mary P., Cofré Lizama, L. Eduardo

• May 12, 2026

Modulation of the immunological and neuroinflammatory microenvironment in older people with multiple sclerosis

• by Oreja-Guevara, Celia , Meuth, Sven G, Grigoriadis, Nikolaos , Vermersch, Patrick , Hartung, Hans-Peter , Sorensen, Per Soelberg , Leocani, Letizia , Schmierer, Klaus , Gold, Ralf , Fernández, Óscar Fernández

• May 19, 2026

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

• by Kathryn Wighton

• June 11, 2026

• 2 min